Experimental weight-loss drug from a small biotech could outdo Ozempic

By The Washington Post
| February 27, 2024

Viking Therapeutics posted results of an experimental drug that showed even better weight loss than the current market-leading drugs, a sign that the dominance of Ozempic and Mounjaro is far from assured.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Hospital leaders are increasingly turning to automation to streamline revenue cycle operations, but should some processes be left behind? ...